Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Yan

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2019
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapyHuan Tang, Meng Ma, Jie Dai, et al.
Translational Oncology|July 16, 2017
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose InterferonJiayi Yu, Xiaowen Wu, Huan Yu, et al.
Journal of Translational Medicine|December 6, 2017
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapyHuan Yu, Meng Ma, Junya Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2017
Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitorJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 17, 2025
Evaluating the prognostic significance of tumor deposits in gastric cancer and strategies for their integration into the TNM staging system: a single-center retrospective studyJun Yu, Ruirong Yao, Ning Han, et al.
Journal of Cancer|February 6, 2019
Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation SequencingJiayi Yu, Xiaowen Wu, Junya Yan, et al.
Frontiers in Oncology|March 6, 2024
Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort studyLinbin Lu, Wenzheng Fang, Jun Yu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2025
Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort studyYan Pan, Linbin Lu, Xianchun Gao, et al.
Cancer Medicine|August 21, 2023
Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancerXianchun Gao, Weili Han, Ling Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2017
Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted TherapyYan Kong, Xinan Sheng, Xiaowen Wu, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2019
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapyHuan Tang, Meng Ma, Jie Dai, et al.
Translational Oncology|July 16, 2017
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose InterferonJiayi Yu, Xiaowen Wu, Huan Yu, et al.
Journal of Translational Medicine|December 6, 2017
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapyHuan Yu, Meng Ma, Junya Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2017
Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitorJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 17, 2025
Evaluating the prognostic significance of tumor deposits in gastric cancer and strategies for their integration into the TNM staging system: a single-center retrospective studyJun Yu, Ruirong Yao, Ning Han, et al.
Journal of Cancer|February 6, 2019
Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation SequencingJiayi Yu, Xiaowen Wu, Junya Yan, et al.
Frontiers in Oncology|March 6, 2024
Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort studyLinbin Lu, Wenzheng Fang, Jun Yu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2025
Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort studyYan Pan, Linbin Lu, Xianchun Gao, et al.
Cancer Medicine|August 21, 2023
Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancerXianchun Gao, Weili Han, Ling Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2017
Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted TherapyYan Kong, Xinan Sheng, Xiaowen Wu, et al.
Pageof 4